Related by context. Frequent words. (Click for all words.) 70 Small Molecule 66 Presents Positive 65 RNAi Therapeutics 64 Preclinical Data 63 Drug Candidate 63 Preclinical Development 63 Phase III Clinical Trial 63 Clinical Trial Results 62 FDA Accepts 62 Study Demonstrates 62 Patient Enrollment 62 Genetic Testing 62 FDA Clears 61 Cholesterol Drug 61 Phase III Trial 60 Cancer Vaccines 60 Generic Version 60 Completes Enrollment 60 Small Molecules 60 Cervical Cancer Vaccine 60 Idera Pharmaceuticals 60 Inc Therapeutic Competitors 60 Patent Covering 60 Exclusive License 60 Malaria Vaccine 60 Anti Inflammatory 59 Monoclonal Antibody 59 Study Indicates 59 Poster Presentation 59 Announces Presentation 59 Hepatitis C Virus 59 Atopic Dermatitis 59 ImmunoCellular Therapeutics 59 Smallpox Vaccine 59 Autoimmune Diseases 59 Autoimmune Disease 59 Announces Initiation 58 Cancer Immunotherapy 58 Pivotal Phase III 58 Innovative Approach 58 Receives Patent 58 Announce Collaboration 58 Achieves Milestone 58 Recombinant Human 58 Summarizes 58 Preclinical Studies 57 Files Shelf Registration Statement 57 Cancer Vaccine 57 Shows Promise 57 Initiate Phase 57 Metabasis Therapeutics 57 Regado Biosciences 57 Fibrocell Science Inc. 57 Prostate Cancer Patients 57 Exploit collaboration 57 Transcept Pharmaceuticals 56 Issues Guidance 56 Patent Issued 56 Clinical Outcomes 56 Study Confirms 56 Provides Guidance 56 Cancer Treatments 56 Patent Lawsuit 56 Awarded Patent 56 Option Grants 56 Breast Cancer Treatment 56 Influenza Vaccine 56 Prostate Cancer Treatment 56 Announces Issuance 56 Gastric Cancer 56 Pulmonary Arterial Hypertension 56 Hybridon 56 Study Identifies 56 Regains Compliance With 56 Flu Vaccines 55 Monoclonal Antibodies 55 Oral Presentation 55 Tranzyme Pharma 55 Pivotal Trial 55 Drug Makers 55 Announces Stockholder Approval 55 Venous Thromboembolism 55 Holds Promise 55 Novel Approach 55 Complete Merger 55 Meta Analysis 55 Commercialize 55 #:#-# [006] 55 Immunogenicity 55 Regains Compliance 55 Biomaterial 55 Insights Into 55 Explore Strategic Alternatives 55 Announces Successful Completion 55 Biotherapeutics 55 Announces Enhancements 55 Non Invasive 55 Drug Resistant 55 Licensing Deal 55 Newly Diagnosed 55 Discontinues